{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:56:00Z","timestamp":1792112160749,"version":"4.4.0"},"reference-count":5,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"DOI":"10.1136\/bmj-2026-100894","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:15:14Z","timestamp":1789661714000},"page":"e100894","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["US-UK drug pricing deal: MPs urge National Audit Office to investigate costs"],"prefix":"10.1136","volume":"394","author":[{"given":"Tom","family":"Moberly","sequence":"first","affiliation":[{"name":"The BMJ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"2026091713300787000_394.sep17_11.e100894.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.r2538"},{"key":"2026091713300787000_394.sep17_11.e100894.2","doi-asserted-by":"crossref","unstructured":"Cross S, Claxton K, Hill A. Analysis. Health costs of the UK-US trade deal on pharmaceuticals. BMJ 2026;394:e340588.","DOI":"10.1136\/bmj-2026-340588"},{"key":"2026091713300787000_394.sep17_11.e100894.3","unstructured":"Moran L. Investigation into the costs and value for money of the UK-US Pharmaceuticals pricing arrangement. UK Parliament. 15 Sep 2026. https:\/\/committees.parliament.uk\/publications\/55041\/documents\/305148\/default"},{"key":"2026091713300787000_394.sep17_11.e100894.4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2026-191827"},{"key":"2026091713300787000_394.sep17_11.e100894.5","unstructured":"Stein T. UK-US medicines deal: the public interest in publishing the evidence behind it. Nuffield Trust. 27 Aug 2026. https:\/\/www.nuffieldtrust.org.uk\/news-item\/uk-us-medicines-deal-the-public-interest-in-publishing-the-evidence-behind-it"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj-2026-100894","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj-2026-100894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:30:15Z","timestamp":1789677015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj-2026-100894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":5,"alternative-id":["10.1136\/bmj-2026-100894"],"URL":"https:\/\/doi.org\/10.1136\/bmj-2026-100894","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]}}}